冠心病合并糖尿病与单纯冠心病危险因素及临床特点分析(2)
[2] 胡玉刚,李晓宁,万静.冠心病监护室患者发生急性肾损伤和住院死亡的情况及其危险因素[J].中华肾脏病杂志,2017,33(2):92-99.
[3] 宋炜,李杰.绝经后女性2型糖尿病合并冠心病的危险因素分析[J].中国医药导报,2015,12(21):35-38.
[4] 印章.湖北仙桃地区冠心病危险因素的Logistic回归分析[J].微循环学杂志,2015,25(3):69-71.
[5] 刘宁,兰青,文书银.冠心病行经皮冠状动脉介入治疗手术患者支架内再狭窄的危险因素研究[J].中国现代医学杂志,2015,25(18):101-104.
[6] 渠文焕.围绝经期女性冠心病患者的危险因素及临床特点分析[J].中西医结合心血管病杂志:电子版,2015,3(36):40-41.
[7] Wong JM,Sin NL,Whooley MA,et al.A comparison of cook-medley hostility subscales and mortality in patients with coronary heart disease: Data from the heart and soul study[J].Psychosomatic Medicine: Journal of the American Psycho somatic Society,2014,76(4):311-317.
[8] 李强.冠心病患者应用氯吡格雷引起的抵抗发生率及其危险因素[J].中国当代医药,2016,23(7):35-37.
[9] Girinsky T,M'Kacher R,Lessard N,et al.Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: Results and risk factor analysis[J].International Journal of Radiation Oncology, Biology, Physics,2014,89(1):59-66.
[10] 高靜,王晨菲,王敏哲,等.221例维吾尔族2型糖尿病合并冠心病临床特点及危险因素分析[J].辽宁医学院学报,2015,36(5):26-28., 百拇医药(姜春华)
[3] 宋炜,李杰.绝经后女性2型糖尿病合并冠心病的危险因素分析[J].中国医药导报,2015,12(21):35-38.
[4] 印章.湖北仙桃地区冠心病危险因素的Logistic回归分析[J].微循环学杂志,2015,25(3):69-71.
[5] 刘宁,兰青,文书银.冠心病行经皮冠状动脉介入治疗手术患者支架内再狭窄的危险因素研究[J].中国现代医学杂志,2015,25(18):101-104.
[6] 渠文焕.围绝经期女性冠心病患者的危险因素及临床特点分析[J].中西医结合心血管病杂志:电子版,2015,3(36):40-41.
[7] Wong JM,Sin NL,Whooley MA,et al.A comparison of cook-medley hostility subscales and mortality in patients with coronary heart disease: Data from the heart and soul study[J].Psychosomatic Medicine: Journal of the American Psycho somatic Society,2014,76(4):311-317.
[8] 李强.冠心病患者应用氯吡格雷引起的抵抗发生率及其危险因素[J].中国当代医药,2016,23(7):35-37.
[9] Girinsky T,M'Kacher R,Lessard N,et al.Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: Results and risk factor analysis[J].International Journal of Radiation Oncology, Biology, Physics,2014,89(1):59-66.
[10] 高靜,王晨菲,王敏哲,等.221例维吾尔族2型糖尿病合并冠心病临床特点及危险因素分析[J].辽宁医学院学报,2015,36(5):26-28., 百拇医药(姜春华)